{
    "eid": "2-s2.0-85041898151",
    "title": "Incidence of infusion hypersensitivity reaction after withholding dexamethasone premedication in early breast cancer patients not experiencing two previous cycles of infusion hypersensitivity reaction for weekly paclitaxel chemotherapy",
    "cover-date": "2018-07-01",
    "subject-areas": [
        {
            "@_fa": "true",
            "$": "Oncology",
            "@code": "2730",
            "@abbrev": "MEDI"
        }
    ],
    "keywords": [
        "Dexamethasone premedication",
        "Infusion hypersensitivity reaction",
        "Paclitaxel"
    ],
    "authors": [
        "Napa Parinyanitikul",
        "Walailuk Tanpipattanakul",
        "Nattaya Poovorawan",
        "Thanapoom Rattananupong",
        "Poranee Laoitthi",
        "Piyada Sithidetphaiboon",
        "Suebpong Thanasanvimon",
        "Virote Sriuranpong"
    ],
    "citedby-count": 10,
    "ref-count": 23,
    "ref-list": [
        "European-Canadian randomized trial of paclitaxel in relapsed ovarian cancer: high dose versus low dose and long versus short infusion",
        "Cyclophosphamide and cisplatin compared with paclitaxel and cisplatin in patient with stage III and IV ovarian cancer",
        "Paclitaxel plus carboplatin versus gemcitabine plus paclitaxel in non-small cell lung cancer: a phase III randomized trial",
        "Simplified regimen for the prevention of paclitaxel-associated hypersensitivity reaction",
        "Carboplatin and paclitaxel in ovarian cancer: a phase I study of Gynecologic Oncology Group",
        "Single-dose dexamethasone paclitaxel premedication",
        "Paclitaxel-associated hypersensitivity reaction: experience of the gynecologic oncology program of the Cleveland Clinic Cancer Center",
        "Role of formulation vehicles in taxanepharmacology",
        "Allergic reaction associatied with cremophor E containing antineoplastic",
        "Inter-relationships of paclitaxel disposition, infusion duration and cremophor EL kinetics in cancer patients",
        "Formation of complement activating particle in aqueous solution of Taxol: possible role in hypersensitivity reaction",
        "Hypersensitivity reactions from taxol",
        "Incidence and risk factors for paclitaxel hypersensitivity during ovarian cancer chemotherapy",
        "A search for predictive factors for hypersensitivity reactions to paclitaxel and platinum salts in chemotherapy for gynecologic pelvic neoplasm",
        "Premedication strategy for weekly paclitaxel",
        "Tapering and discontinuation of glucocorticoid prophylaxis during prolonged weekly to biweekly paclitaxel administration",
        "Rates of adverse events with low-dose dexamethasone (Dex) as premedication of weekly paclitaxel (Pac) utilized as adjuvant/neoadjuvant therapy for operable breast cancer",
        "Stop paclitaxel premedication after two doses in patients not experiencing a previous infusion hypersensitivity reaction",
        "Feasibility of stopping paclitaxel premedication after two dose in patients not experiencing a previous infusion hypersensitivity reaction",
        "Feasibility of withholding dexamethasone premedication in weekly paclitaxel administration and its associated adverse reactions",
        "Retrospective evaluation of weekly paclitaxel hypersensitivity reactions reported utilizing an electronic medical record system at a tertiary cancer center",
        "Dose reduction of steroid premedication for paclitaxel: no increase of hypersensitivity reactions",
        "A comparison of two prophylactic regimen for hypersensitivity reaction to paclitaxel"
    ],
    "affiliation": {
        "affiliation-city": "Bangkok",
        "@id": "60022183",
        "affilname": "King Chulalongkorn Memorial Hospital",
        "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60022183",
        "affiliation-country": "Thailand"
    },
    "funding": [
        "King Chulalongkorn Memorial Hospital",
        "Chulalongkorn University"
    ]
}